The FDA is Halted on ADHD Drug Research

 

There is a new ADHD drug that is being reviewed by the FDA. The FDA is giving the drug a thorough investigation to make sure that there will not be any heart problems in both children and adults. Although this is a serous investigation, the end result of a positive ADHD drug that can be made available for consumption is always on the lookout from those who suffer with the disease. According to various reports, the FDA had begun its preliminary research, but had to halt the process due to financial set backs.

 

The FDA does, however, have every plan to reinstate the investigation process of the drug once there are additional funds that can be use for the medication. The FDA plans to research 500,000 patients who were diagnosed to take the medication. This should prove to be beneficial for study and trends.